ClinicalTrials.Veeva

Menu

Response Inhibition in Tourette Syndrome

Cincinnati Children's Hospital Medical Center logo

Cincinnati Children's Hospital Medical Center

Status

Completed

Conditions

Tourette Syndrome

Treatments

Device: Repetitive TMS

Study type

Interventional

Funder types

Other

Identifiers

NCT03628703
CIN001 - TAA2018

Details and patient eligibility

About

Tics are the hallmark symptoms in Tourette Syndrome. Patients with Tourette Syndrome have difficulties controlling unwanted movements. The ability to control the motor system involves the pre-supplementary motor area (pre-SMA) in the brain. In this study, we will use Transcranial Magnetic Stimulation to modulate the pre-SMA and determine effect on the ability to stop an unwanted action in a behavior task (stop signal task).

Enrollment

10 patients

Sex

All

Ages

10 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Tourette Syndrome

Exclusion criteria

  • Autism spectrum disorder
  • Mood disorder
  • Epilepsy
  • Implanted medical device (e.g. pacemaker, shunt, pumps)

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Repetitive TMS
Experimental group
Description:
Repetitive Intermittent Theta-Burst Transcranial Magnetic Stimulation
Treatment:
Device: Repetitive TMS

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Steve W. Wu, MD; Hannah Jackson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems